Results

Total Results: 273 records

Showing results for "bone density".
Users also searched for: dexa

  1. hcup-us.ahrq.gov/reports/methods/2006_4.pdf
    January 01, 2006 - HCUP_methods_series_cover.ai HCUP Methods Series kbr33831 Contact Information: Healthcare Cost and Utilization Project (HCUP) Agency for Healthcare Research and Quality 540 Gaither Road Rockville, MD 20850 http://www.hcup-us.ahrq.gov For Technical Assistance with HCUP Products: Email: hcup@ahr…
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-diabetes-rapid-research.pdf
    November 01, 2024 - Linking Dental Services to Treatment Outcomes for Diabetes: A Rapid Response Review Rapid Evidence Product Linking Dental Services to Treatment Outcomes for Diabetes: A Rapid Response Review Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lan…
  3. www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA0087-NCINQSexualActivityStatusForm.pdf
    February 06, 2012 - effectiveness for preventing pregnancy, potential side effects, and long­ term consequences (eg, potential bonedensity concerns with depot medroxyprogesterone acetate).
  4. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-and-ovarian-cancer-brca-testing-screening-2005
    September 15, 2005 - Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures.
  5. www.uspreventiveservicestaskforce.org/home/getfilebytoken/3HxQuXnyqHpUKNqjB7hWBw
    September 01, 2005 - Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures.
  6. www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/highlights/ps-project-highlights-medication-safety.pdf
    April 30, 2025 - implemented four enhanced actionable reminders targeting performance of annual mammography, one-time bone-density
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendix-c-prepub-final.xlsx
    January 01, 2025 - Table C-1. KQ 3,4, 5 Char. Table C-1 Characteristics of included studies KQ 3, KQ 4, and KQ 5 First Author Last Name Year of Publication Citation Study Cohort Name Study Registration Number Related Publications Study Funder Country Study Design Population Narrative Age (years) Eligible Minimum Age Actual Minimum Age …
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-final-app-c.xlsx
    January 01, 2025 - Table C-1. KQ 3,4, 5 Char. Table C-1 Characteristics of included studies KQ 3, KQ 4, and KQ 5 First Author Last Name Year of Publication Citation Study Cohort Name Study Registration Number Related Publications Study Funder Country Study Design Population Narrative Age (Years) Eligible Minimum Age Actual Minimum Age …
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/binge-eating_executive.pdf
    December 01, 2015 - 1 Comparative Effectiveness Review Number 160 Management and Outcomes of Binge-Eating Disorder Executive Summary Background Definition of Binge-Eating Disorder and Loss-of-Control Eating Binge-eating disorder (BED) is characterized by recurrent episodes of binge eating—i.e., eating episodes that occur in …
  10. effectivehealthcare.ahrq.gov/sites/default/files/hip-fracture-pain_surveillance.pdf
    July 08, 2015 - Surveillance Report: CER 30: Comparative Effectiveness of Pain Management for Hip Fracture AHRQ Comparative Effectiveness Review Surveillance Program CER #30: Comparative Effectiveness of Pain Management Interventions for Hip Fracture …
  11. www.ahrq.gov/downloads/pub/evidence/pdf/bariatricrep/barirep.pdf
    November 01, 2008 - Bariatric Surgery in Women of Reproductive Age: Special Concerns for Pregnancy. Evidence Report/Technology Assessment, No. 169 Evidence Report/Technology Assessment Number 169 Bariatric Surgery in Women of Reproductive Age: Special Concerns for Pregnancy Prepared for: Agency for Healthcare Research…
  12. effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
    December 01, 2013 - especially in African Americans. 48 Also, the long-term use has been associated with a decline in bonedensity, which is attributed to emtricitabine. 48 FDA approved emtricitabine/tenofovir (Truvada
  13. effectivehealthcare.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
    January 01, 2012 - , especially in African Americans. 68 Also, long-term use has been associated with a decline in bonedensity, which is attributed to emtricitabine. 68 In June 2011, a letter from the AIDS Healthcare

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive